期刊文献+

儿童免疫性血小板减少症预后相关因素 被引量:24

Prognostic factors in immune thrombocytopenia in children
原文传递
导出
摘要 目的探讨初诊外周血淋巴细胞绝对值(ALC)与儿童原发性免疫性血小板减少症(ITP)预后的关系,为临床判断儿童ITP预后及治疗提供依据。方法回顾性分析贵州医科大学附属医院2014年1月至2018年3月收治的166例ITP患儿的临床资料,并采用门诊及电话随访的方式对与儿童ITP预后有关的因素(性别、年龄、民族、诱因、出血情况、初诊时ALC、血小板计数及治疗方式)进行统计学分析,观察外周血ALC与儿童ITP预后的关系。结果166例ITP患儿中,89例(53.6%)3个月内缓解,18例(10.8%)3~12个月缓解,20例(12.0%)1~4年缓解,39例(23.5%)1~10年未缓解,1年内缓解率为64.5%,总缓解率为76.4%。3个月内、3~12个月、1~4年缓解患儿中ALC分别为(4.58±2.87)×10^9/L、(4.47±2.04)×10^9/L和(2.86±1.61)×10^9/L,共有39例(23.5%)属于难治病例(1~10年未缓解),其ALC为(2.07±0.98)×10^9/L,组间比较差异有统计学意义(F=12.06,P<0.01)。单因素分析显示年龄(F=27.28)、发病前有感染史及预防接种史(χ^2=9.31)、初诊时ALC(F=12.06)与患儿预后相关(均P<0.05)。多因素分析显示发病前有感染史及预防接种史(95%CI:0.19~1.51,P<0.05)、初诊时ALC(95%CI:-0.64^-0.23,P<0.001)是影响患儿预后的独立影响因素。以是否发展为慢性(病程>12个月)为状态变量、ALC为检验变量绘制受试者工作特征曲线(ROC)选择最佳的界限值,曲线下面积(AUC)为0.765(P<0.05),截点值为3.925×10^9/L,敏感度为0.542,特异度为0.966。结论初诊时ALC可作为儿童ITP评估预后指标之一,低ALC是儿童ITP慢性发展的危险信号。 Objective To explore the prognostic relationship between initial absolute lymphocyte count(ALC) of peripheral blood and primary immune thrombocytopenia (ITP) in children, in order to provide basis for judging the prognosis and treatment of ITP in children. MethodsClinical data of 166 children with primary ITP in children admi-tted at the Affiliated Hospital of Guizhou Medical University from January 2014 to March 2018 were analyzed retrospectively, and they were followed up by clinic and telephone, the prognostic factors (gender, age, ethnicity, inducement, bleeding, initial ALC, platelet count and treatment) were statistically analyzed, and the relationship between ALC of peripheral blood and the prognosis of children with ITP was observed. ResultsOf 166 children with ITP, 89 cases (53.6%) had remission within 3 months, 18 cases (10.8%) within 3-12 months, 20 cases (12.0%) within 1-4 years, a total of 39 cases (23.5%) were refractory (no remission in 1-10 years), the remission rate within 1 year was 64.5%, the total remission rate was 76.4%.ALC of remission cases was (4.58±2.87)×10^9/L within 3 months,(4.47±2.04)×10^9/L within 3-12 months, and (2.86±1.61)×10^9/L within 1- 4 years.Thirty-nine cases (23.5%) were refractory(no remission in 1-10 years), ALC of them was (2.07±0.98)×10^9/L, and there were significant differences among different groups (F= 12.06, P<0.01). Univariate analysis showed that age (F=27.28), pre-morbidity history of infection and vaccination history(χ^2= 9.31), initial ALC (F=12.06) at initial diagnosis were related with the prognosis of children with ITP (all P<0.05). Multivariate analysis showed that the history of infection before onset, the history of vaccination(95%CI: 0.19 to 1.51, P<0.05)and initial ALC(95%CI:-0.64 to -0.23, P<0.001) at the time of initial diagnosis were independent factors affecting the prognosis of children with ITP.The receivers operating characteristic (ROC) was drawn with the development of chronic disease (course >12 months) as state variable and ALC as test variable.The area under curve(AUC) was 0.765(P<0.05), cut-off point was 3.925×10^9/L, sensitivity was 0.542, and specificity was 0.966. ConclusionsInitial ALC can be used as one of the prognosis index of ITP in children, and low ALC is the risk signal for chronic development of ITP in children.
作者 童汝雁 金皎 黄璟 陈桂芳 何志旭 Tong Ruyan;Jin Jiao;Huang Jing;Chen Guifang;He Zhixu(Department of Pediatric Hematology,Affiliated Hospital of Guizhou Medical University,Guiyang 550004,China)
出处 《中华实用儿科临床杂志》 CSCD 北大核心 2019年第11期837-841,共5页 Chinese Journal of Applied Clinical Pediatrics
基金 贵州省科学技术厅(黔科合平台人才〔2019〕5406号) 贵阳医学院科技厅联合基金(黔科合LG字〔2011〕043号).
关键词 免疫性血小板减少症 淋巴细胞绝对值 预后 Immune thrombocytopenia Absolute lymphocyte count Prognosis
  • 相关文献

参考文献10

二级参考文献133

  • 1Yong M, Schoonen WM, Li L, et al. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. Br J Haematol, 2010, 149: 855-864.
  • 2Rosthcj S, Hedlund-Treutiger I, Rajantie J, et al. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children : A prospective nordic study of an unselected cohort. J Pediatr, 2003, 143:302-307.
  • 3Kiihne T, Buchanan GR, Zimmetlan S, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group. J Pediatr, 2003, 143 : 605 -608.
  • 4British Committee for Standards in Hematology General Hematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003. 120:574-596.
  • 5Geddis AE, Balduini CL. Diagnosis of immune thrombocytopenicpurpura in children. Curr Opin Hematol, 2007,14:520-525.
  • 6Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenie purpura of adults and children: report from an international working group. Blood, 2009, 113:2386-2393.
  • 7Blanehette V, Carcao M. Approach to the investigation and management of immune thrombocytopenie purpura in children. Semin Hematol, 2000,37:299-314.
  • 8Beck CE, Nathan PC, Parkin PC, et al. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J Pediatr, 2005, 147:521-527.
  • 9Gaines AR. Disseminated intravascular coagulation associated with acutehemoglobinemia or hemoglobinuria following Rh (0) (D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood, 2005,106 : 1532-1537.
  • 10Hedlund-Treutiger I, Henter JI, Elinder G. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol, 2003, 25:139-144.

共引文献262

同被引文献130

引证文献24

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部